The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
Open accessAbstract
Culture-based blood–brain barrier (BBB) models are crucial tools to enable rapid screening of brain-penetrating drugs. However, reproducibility of in vitro barrier properties and permeability remain as major challenges. Here, we report that self-assembling multicellular BBB spheroids display reproducible BBB features and functions. The spheroid core is comprised mainly of astrocytes, while brain endothelial cells and pericytes encase the surface, acting as a barrier that regulates transport of molecules. The spheroid surface exhibits high expression of tight junction proteins, VEGF-dependent permeability, efflux pump activity and receptor-mediated transcytosis of angiopep-2. In contrast, the transwell co-culture system displays comparatively low levels of BBB regulatory proteins, and is unable to discriminate between the transport of angiopep-2 and a control peptide. Finally, we have utilized the BBB spheroids to screen and identify BBB-penetrant cell-penetrating peptides (CPPs). This robust in vitro BBB model could serve as a valuable next-generation platform for expediting the development of CNS therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Tight junctions of the blood–brain barrier
Wolburg, H., & Lippoldt, A. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,183
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
P-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 960
Pathophysiological consequences of VEGF-induced vascular permeability
Weis, S. M., & Cheresh, D. A. (2005) · Nature · doi:10.1038/nature03987 · Cited by 909
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Uchida, Y., Ohtsuki, S., Katsukura, Y., Ikeda, C., Suzuki, T., Kamiie, J., & Terasaki, T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07208.x · Cited by 881
The hCMEC/D3 cell line as a model of the human blood brain barrier
Weksler, B., Romero, I. A., & Couraud, P.-O. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-16 · Cited by 753
Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)
Booth, R., & Kim, H. (2012) · Lab on a Chip · doi:10.1039/c2lc40094d · Cited by 739
Endothelial Cell Heterogeneity
Aird, W. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006429 · Cited by 731
A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes
Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, Á., Tanaka, K., & Niwa, M. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.002 · Cited by 728
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676
VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown
Argaw, A. T., Gurfein, B. T., Zhang, Y., Zameer, A., & John, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808698106 · Cited by 666
Modelling of the blood–brain barrier in drug discovery and development
Cecchelli, R., Berezowski, V., Lundquist, S., Culot, M., Renftel, M., Dehouck, M.-P., & Fenart, L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2368 · Cited by 618
Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557
Griep, L. M., Wolbers, F., de Wagenaar, B., ter Braak, P. M., Weksler, B. B., Romero, I. A., Couraud, P. O., Vermes, I., van der Meer, A. D., & van den Berg, A. (2013) · Biomedical Microdevices · doi:10.1007/s10544-012-9699-7 · Cited by 537
Maira, S.-M., Pecchi, S., Huang, A., Burger, M., Knapp, M., Sterker, D., Schnell, C., Guthy, D., Nagel, T., Wiesmann, M., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0474 · Cited by 529
Identification and Design of Peptides as a New Drug Delivery System for the Brain
Demeule, M., Régina, A., Ché, C., Poirier, J., Nguyen, T., Gabathuler, R., Castaigne, J.-P., & Béliveau, R. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131318 · Cited by 462
Structural and functional aspects of the blood-brain barrier
Begley, D. J., & Brightman, M. W. (2003) · Peptide Transport and Delivery into the Central Nervous System · doi:10.1007/978-3-0348-8049-7_2 · Cited by 445
Eigenmann, D. E., Xue, G., Kim, K. S., Moses, A. V., Hamburger, M., & Oufir, M. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-33 · Cited by 421
Copper‐Catalyzed Azide–Alkyne Click Chemistry for Bioconjugation
Presolski, S. I., Hong, V. P., & Finn, M. G. (2011) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch110148 · Cited by 416
SyM-BBB: a microfluidic blood brain barrier model
Prabhakarpandian, B., Shen, M.-C., Nichols, J. B., Mills, I. R., Sidoryk-Wegrzynowicz, M., Aschner, M., & Pant, K. (2013) · Lab on a Chip · doi:10.1039/c2lc41208j · Cited by 339
Hatherell, K., Couraud, P.-O., Romero, I. A., Weksler, B., & Pilkington, G. J. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.05.012 · Cited by 334
A fully automated flow-based approach for accelerated peptide synthesis
Mijalis, A. J., Thomas, D. A., Simon, M. D., Adamo, A., Beaumont, R., Jensen, K. F., & Pentelute, B. L. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2318 · Cited by 329
Self-citationIn vitro models of the blood-brain barrier
Wilhelm, I., Fazakas, C., & Krizbai, I. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1828 · Cited by 298
In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies
Naik, P., & Cucullo, L. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23022 · Cited by 288
Gumbleton, M., & Audus, K. L. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1119 · Cited by 286
In Vitro Models of the Blood-Brain Barrier
Neuhaus, W. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_370 · Cited by 236
Proescholdt, M. A., Heiss, J. D., Walbridge, S., Mühlhauser, J., Capogrossi, M. C., Oldfield, E. H., & Merrill, M. J. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199906000-00006 · Cited by 226
Santaguida, S., Janigro, D., Hossain, M., Oby, E., Rapp, E., & Cucullo, L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.027 · Cited by 209
Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo
Stalmans, S., Bracke, N., Wynendaele, E., Gevaert, B., Peremans, K., Burvenich, C., Polis, I., & De Spiegeleer, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139652 · Cited by 209
Electron microscopic features and proliferation of astrocytes in the corpus callosum of the rat
Mori, S., & Leblond, C. P. (1969) · Journal of Comparative Neurology · doi:10.1002/cne.901370206 · Cited by 205
Mittapalli, R. K., Vaidhyanathan, S., Dudek, A. Z., & Elmquist, W. F. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201475 · Cited by 179
Dantzig, A. H., Shepard, R. L., Law, K. L., Tabas, L., Pratt, S., Gillespie, J. S., Binkley, S. N., Kuhfeld, M. T., Starling, J. J., & Wrighton, S. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34974-2 · Cited by 179
Rapid Flow-Based Peptide Synthesis
Heider, P. L., Adamo, A., Vinogradov, A. A., Li, X., Berger, T., Policarpo, R. L., Zhang, C., Zou, Y., Liao, X., Spokoyny, A. M., et al. (2013) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 173
Self-citationMulticellular Self-Assembled Spheroidal Model of the Blood Brain Barrier
Urich, E., Patsch, C., Aigner, S., Graf, M., Iacone, R., & Freskgård, P.-O. (2013) · Scientific Reports · doi:10.1038/srep01500 · Cited by 165
Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
Zou, L.-L., Ma, J.-L., Wang, T., Yang, T.-B., & Liu, C.-B. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311020006 · Cited by 163
Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery
Xia, H., Gao, X., Gu, G., Liu, Z., Hu, Q., Tu, Y., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.029 · Cited by 160
Boersma, M., Haase, H. S., Peterson‐Kaufman, K. J., Lee, E. F., Clarke, O. B., Colman, P. M., Smith, B. J., Horne, W. S., Fairlie, W. D., & Gellman, S. H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207148m · Cited by 156
Liu, X., Ide, J. L., Norton, I. H., Marchionni, M. A., Ebling, M. C., Wang, L. Y., Davis, E., Sauvageot, C., Kesari, S., Kellersberger, K. A., et al. (2013) · Scientific Reports · doi:10.1038/srep02859 · Cited by 134
Self-citationVu, K., Weksler, B., Romero, I., Couraud, P.-O., & Gelli, A. (2009) · Eukaryotic Cell · doi:10.1128/ec.00240-09 · Cited by 124
Imaging Approach to Mechanistic Study of Nanoparticle Interactions with the Blood–Brain Barrier
Bramini, M., Dong, Y., Hallerbach, A., Raghnaill, M. N., Salvati, A. L., Åberg, C., & Dawson, K. A. (2014) · ACS Nano · doi:10.1021/nn5018523 · Cited by 123
Rousselle, C., Clair, P., Smirnova, M., Kolesnikov, Y. A., Pasternak, G. W., Gac-Breton, S., Rees, A. R., Scherrmann, J., & Temsamani, J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.048520 · Cited by 90
Cells meeting our immunophenotypic criteria of endothelial cells are large platelets
Strijbos, M. H., Kraan, J., den Bakker, M. A., Lambrecht, B. N., Sleijfer, S., & Gratama, J. W. (2007) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20156 · Cited by 68
Edwards, A., Wachter, F., Lammert, M., Huhn, A. J., Luccarelli, J., Bird, G. H., & Walensky, L. D. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00214 · Cited by 45
Jindatip, D., Fujiwara, K., Kouki, T., & Yashiro, T. (2012) · Anatomical Science International · doi:10.1007/s12565-012-0144-z · Cited by 26
Cited by
Campisi, M., Shin, Y., Osaki, T., Hajal, C., Chiono, V., & Kamm, R. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.014 · Cited by 718
Development and Cell Biology of the Blood-Brain Barrier
Langen, U. H., Ayloo, S., & Gu, C. (2019) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062608 · Cited by 511
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 466
Wevers, N. R., Kasi, D. G., Gray, T., Wilschut, K. J., Smith, B., van Vught, R., Shimizu, F., Sano, Y., Kanda, T., Marsh, G., et al. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0108-3 · Cited by 353
Advances and perspectives in organic sonosensitizers for sonodynamic therapy
Xing, X., Zhao, S., Xu, T., Huang, L., Zhang, Y., Lan, M., Lin, C., Zheng, X., & Wang, P. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214087 · Cited by 334
Metadata
- Authors
- Cho, C.-F., Wolfe, J. M., Fadzen, C. M., Calligaris, D., Hornburg, K., Chiocca, E. A., Agar, N. Y. R., Pentelute, B. L., & Lawler, S. E.
- Venue
- Nature Communications
- Published
- 2017-06-06
- Volume
- 8
- Issue
- 1
- Pages
- 15623-15623
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2624368609
- Cited by
- 336
- References
- 47
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.